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Abstract
Background: Our institution’s traditional pain management strategy after shoulder arthroplasty has involved the
utilization of postoperative patient-controlled narcotic analgesia. More recently, we have implemented a protocol (TLC)
that utilizes a multimodal approach. The purpose of this study was to determine whether this change has improved
pain control and decreased narcotic utilization.
Methods: Patients undergoing primary total shoulder or reverse arthroplasty were retrospectively studied. All
patients underwent interscalene brachial plexus blockade. “Traditional” patients were provided a patient-controlled
analgesic pump postoperatively. TLC patients were given preoperative and postoperative multimodal, non-narcotic
analgesic medications and breakthrough narcotics. Morphine equivalent units (MEU) consumed and Visual Analog
Scale (VAS) scores for pain (0, 8, 16, and 24 hours) were considered.
Results: There were 108 patients in each group. Total postoperative narcotic consumption in the first 24 postoperative
hours was 38.5 +/- 81.1 MEU in the “Traditional group” compared to 59.3 +/- 59.1 MEU in the TLC group (P<0.001).
Of patients in the TLC group, 88% utilized breakthrough narcotics. VAS pain was significantly higher in the “Traditional
group” at 16 hours (4.1 +/- 2.9 vs 3.2 +/- 2.7, P=0.020) and 24 hours (4.8 +/- 2.7 vs 3.7 +/- 2.6, P=0.004).
Conclusion: Those treated with the TLC protocol had greater narcotic utilization but better VAS pain scores at 24
hours after surgery. Both groups experienced rebound pain. While the TLC protocol led to an improved pain experience,
further modification of the currently protocol may be necessary to reduce overall narcotic utilization.
Level of evidence: III
Keywords: Arthroplasties, Multimodal pain management, Pain management, Pain-postoperative, Shoulder arthroplasty

Introduction
tudies suggest that a multimodal approach to pain
management can lead to decreased pain and narcotic
consumption after total joint arthroplasty and lumbar
spinal procedures (1-4). In theory, multimodal-based
approaches to pain management have the potential to
minimize postoperative pain while, at the same time,
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reducing the total opioid consumption and subsequent
associated deleterious adverse effects. With concern
regarding a pervading opioid epidemic in the United
States, reduction in narcotic utilization after surgery is of
paramount concern (5).
The optimal post-operative pain control regimen after
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total shoulder arthroplasty has not been well studied.
The introduction of interscalene brachial plexus blockade
has resulted in shorter hospital stays, reduced need for
postoperative analgesics, less time in the postanesthesia
care unit and high levels of satisfaction with their
anesthesia (6-11). Despite this, postoperative pain
management remains a concern as patients undergoing
interscalene brachial plexus blockade can experience
failure in up to 20% of cases and many patients experience
“rebound pain”, or a quantifiable increase in acute pain
during the first few hours after the effects of nerve block
resolves (12, 13). Because of this, patients often require
substantial doses of intravenous and oral narcotics after
shoulder arthroplasty.
Our institution’s traditional pain management strategy
after shoulder arthroplasty has involved the utilization
of preoperative interscalene brachial plexus blockade
and postoperative patient-controlled narcotic analgesia.
More recently, we have implemented a protocol (TLC)
that utilizes a preoperative and postoperative multimodal
approach to pain control. The purpose of this study was to
determine whether this change in protocol has improved
pain control and decreased narcotic utilization after
shoulder arthroplasty.
Materials and Methods
This retrospective comparative study was approved
by the Institutional Review Board of Thomas Jefferson
University. The last 108 patients who underwent
primary total shoulder or reverse arthroplasty for the
diagnoses of osteoarthritis or cuff tear arthropathy
under the “Traditional protocol” and the first 108
patients who underwent primary total shoulder or
reverse arthroplasty for the diagnoses of osteoarthritis
or cuff tear arthropathy under the “TLC protocol” were
compared (1/14/2015 to 6/22/2016). Based on a twotailed t-test with 80% power, assuming an effect size
(net difference normalized by within-group standard
deviation) of 0.5 and a P-value for significance of 0.025,
78 patients were required in each group. All surgeries
were performed at a single institution by one of four
fellowship-trained shoulder surgeons. Patients with
psychiatric illness as defined by comorbid diagnosis of
bipolar disorder or schizophrenia, revision arthroplasty
surgery, surgery for a diagnosis of fracture, workman’s
compensation/disability/litigation claim, known adverse
drug reaction or allergy to the medications used, chronic
pain syndromes (including reflex sympathetic dystrophy,
fibromyalgia, chronic diffuse musculoskeletal pain),
patients taking long acting narcotic pain medications
(including extended release narcotic pain medications
and methadone), and patients with hepatic and renal
disease were excluded. Data regarding demographics,
American Society of Anesthesiologists Score (0 – 6),
short-acting narcotic usage, and non-narcotic analgesic
usage were collected prospectively.
Baseline preoperative Visual Analog Pain scores
were obtained on the day of surgery prior to patient
evaluation by the anesthesiologist. Preoperatively, all
patients underwent interscalene brachial plexus blockade
performed by one of 6 anesthesiologists, experienced
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in ultrasound-guided regional anesthesia, using 30ml of
0.5% Ropivacaine.
The Traditional group was given no preoperative
medication and was provided a patient-controlled
analgesic pump in the post-operative ambulatory care unit
(PACU). The pump dispensed hydromorphone with the
dosage and frequency titrated based on the patient’s pain.
No additional oral narcotics were routinely ordered over
the first 24 hours after surgery. In cases of ineffectiveness
or reactions to hydromorphone, patient-controlled
analgesic pumps were altered to dispense either morphine
or fentanyl. Acetaminophen was utilized to treat fever in
the perioperative setting on an “as needed” basis. No other
analgesic or non-steroidal anti-inflammatory medications
were given during the first 24 hours.
Patients in the TLC group were given acetaminophen
975 mg, celecoxib 400 mg, and pregabalin 75 mg orally
2 hours before incision. Postoperatively TLC patients
were given acetaminophen 650 mg by mouth every 6
hours, pregabalin 150 mg by mouth every 12 hours,
and ketorolac 30mg IV q6h. In addition to the TLC
medications, patients in this group were offered one of
the following for breakthrough pain: oxycodone IR 10
mg by mouth every 4 hours as needed, hydromorphone
2 mg by mouth every 4 to 6 hours as needed, tramadol
50mg by mouth every 4 to 6 hours as needed, and
valium 2 by mouth every 12 hours as needed. If none of
the oral medications were successful at relieving pain,
an intravenous fentanyl or hydromorphone PCA was
started at the discretion of the treating physician.
The primary outcome variable was morphine equivalent
units (MEU) consumed over the first 24 hours after
surgery. Secondary outcomes included intraoperative MEU
consumed, Visual Analog Scale (VAS) for pain (0, 8, 16,
and 24 hours), and length of hospital stay. Intraoperative
narcotic administration was at the discretion of the
anesthesiologist. The need for narcotic was generally
determined based on physiologic indicators for pain,
which includes hypertension and tachycardia.
Comparative statistics between groups were performed
using Mann-Whitney tests for continuous variables and
Fisher’s exact test for non-continuous variables. A linear
regression model was utilized to determine associations
between demographic variables and MUE utilized in the
first 24 hours after surgery and VAS pain score at 24 hours
after surgery. All analyses were performed using R 3.2.3
(R Foundation for Statistical Computing, Vienna, Austria).
The primary outcome variable was morphine equivalent
units (MEU) consumed over the first 24 hours after
surgery and the secondary outcome was intraoperative
MEU consumed.
Results
There were 108 patients in the “Traditional group”
and 108 patients in the TLC group. Mean age was
70.7 (+/- 9.5) years in the “Traditional group” and
70.0 (+/- 9.5) in the TLC group (P=0.55). There were
no significant differences in gender, body mass index,
arthroplasty type performed, or American Society of
Anesthesiologists (ASA) Score [Table1]. Similarly, there
were no significant differences in preoperative oral
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Table 1. Preoperative Variables
Variable

Traditional Group

Range

TLC

Range

P-value

Age

70.7 (+/-9.5)

48.8-91.4

70.0 (+/-9.5)

39.5-87.0

0.55

Mean ASA Score

2.5 (+/-0.5)

2-3

2.6 (+/-0.6)

1-4

0.08

BMI

30.1 (+/-6.5)

20.3-53.7

30.0 (+/-6.6)

17.9-50.2

0-10

3.2 (+/-3.5)

Gender (male : female)

52 : 56

Arthroplasty (aTSA:RTSA)

59 : 47

Preoperative Short-Acting Narcotics
Preoperative Non-Narcotics

Preoperative VAS Pain Score

16
32

3.3 (+/-3.3)

57 : 51
66 : 42
22
25

0-10

0.59
0.58
0.97
0.37
0.35
0.89

aTSA = anatomic total shoulder arthroplasty, RTSA = reverse total shoulder arthroplasty, ISBPB = interscalene brachial plexus blockade, ASA =
American Society of Anesthesiologists, VAS = Visual Analog Scale

Figure 1. Intraoperative and Postoperative Narcotic Consumption.

short-acting narcotic usage or non-narcotic analgesic
usage [Table 1]. Preoperative VAS pain scores were
similar between the “Traditional group” and the TLC
group (3.3 +/- 3.3 vs 3.2 +/- 3.5, P=0.89).
Total postoperative narcotic consumption in the first
24 hours after surgery was 38.5 +/- 81.1 MEU in the
“Traditional group” compared to 59.3 +/- 59.1 MEU
in the TLC group (P<0.001) [Figure 1]. Of patients in
the TLC group, 88% (95/108) utilized breakthrough
narcotics in the postoperative setting. Intraoperative
narcotics usage was similar in the “Traditional group”
compared to the TLC group (12.1 +/- 5.8 vs 14.3 +/- 7.0,
P=0.030) [Figure 1]. VAS pain score was similar between
the “Traditional group” and the TLC group at zero (1.0
+/- 2.0 vs 1.3 +/- 2.2, P=0.26) and 8 hours (1.7 +/- 2.5
vs 1.6 +/- 2.2, P=0.96) after surgery [Figure 2]. VAS pain
scores were significantly higher in the “Traditional

group” compared to the TLC group at 16 hours (4.1
+/- 2.9 vs 3.2 +/- 2.7, P=0.020) and 24 hours (4.8 +/2.7 vs 3.7 +/- 2.6, P=0.004) [Figure 2]. Patients in the
“Traditional group” had a statistically significantly
longer length of stay than patients in the TLC group (1.7
+/-0.8 vs 1.5 +/- 0.9 days, P=0.002). In the Traditional
group, 43 (39.8%) patients had 1 day length of stay and
57 patients had a two-day length of stay (52.8%) (Range
1 to 6 days). In the TLC group, 71 (65.7%) patients had 1
day length of stay and 25 patients had a two-day length
of stay (23.1%) (Range 1 to 6 days).
Regression Analysis
Multivariate linear regression models were created
to determine the association between preoperative
variables (demographics, comorbidities, procedure
type, surgeon performing the surgery, preoperative VAS
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Figure 2. Preoperative and Postoperative VAS Pain Scores.

pain score) and the outcomes of 24 hour VAS pain score,
postoperative narcotic consumption in the first 24 hours
after surgery, or intraoperative narcotic consumption.
VAS pain score at 24 hours was associated with higher
preoperative VAS pain score (slope = 0.2114, SE = 0.057,
P=0.0026) irrespective of the treatment group (net
effect -0.548, SE .714, P=0.444). The TLC protocol was
independently predictive of increased post-operative
narcotic use (33.619 units, SE 16.0325, P=0.037) TLC was
not a significant predictor of intra-operative MEU (1.249
units, SE 1.437, P=0.386). There were no significant
interaction terms with TLC and other predictors,
suggesting that age, gender, etc., acted the same in the
TLC as in the Traditional group.

Discussion
Pain management after shoulder arthroplasty can be
challenging and optimal pain management strategies
have yet to be established. Traditionally, opioid
medications have been at the forefront of postoperative
pain management. Unfortunately, narcotic medications
are linked with substantial economic burden of adverse
events, including nausea, vomiting, and constipation,
resulting in high hospital costs, prolonged hospital stays,
and substantial health care resource usage in inpatients
and outpatients (14). Additionally, narcotic addiction
remains a prominent concern in health care (15). The
purpose of this study was to determine whether the
utilization of an oral, multimodal pain management
protocol resulted in an improvement in the postoperative
pain experience and reduction in the need for narcotics
after shoulder arthroplasty. Though the specific TLC
protocol utilized in this study led to improved pain
experience at 24 hours, there was a greater overall
utilization of narcotics.
In this study, a combination of 3 medications was

administered before surgery and a different combination
of 3 medications was administered after surgery in the
TLC group. Additionally, a large percentage of patients
in the TLC group still required breakthrough narcotic
medications postoperatively. Because of this, even
though patients in the TLC group reported improved
pain scores at 24 hours after surgery, it is impossible to
determine whether this difference was a result of any
specific medication in the “cocktail”, the multimodal
pathway as a whole, or the greater consumption of
postoperative narcotics. The multimodal pathway used in
this study included the nonsteroidal anti-inflammatory
drug (NSAID), ketorolac. No studies specifically evaluate
the effect of NSAIDs after shoulder arthroplasty. Takada
et al compared the analgesic effect of IV flurbiprofen
with placebo after arthroscopic rotator cuff repair in a
randomized, double-blinded clinical trial (16). Patients
who received flurbiprofen (1mg/kg) five minutes before
surgery reported improved pain scores for the first 6
hours after surgery and reduced narcotic consumption
for the first 2 hours after surgery. There was no difference
in narcotic consumption or pain scores beyond 6 hours
after surgery. Given the potential side-effects of NSAIDs,
including negative influence on tissue healing and bone
metabolism, further study will be necessary to determine
whether a true benefit exists acutely after shoulder
arthroplasty (17, 18). Pregabalin was also included in
the TLC group both preoperatively and postoperatively.
Previous studies have not specifically evaluated the
efficacy of pregabalin as an adjunct to pain management
protocols after shoulder arthroplasty. In a randomized
controlled trial of patients undergoing arthroscopic
shoulder surgery, 60 patients were randomly assigned
to receive either pregabalin (150 mg) or placebo one
hour before anesthetic induction (19). Patients in the
pregabalin group consumed less narcotic over the first
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48 hour after surgery and reported significantly less
pain at 6, 24, and 48 hours after surgery. The inclusion
of pregabalin in our TLC protocol did not appear to
decrease the need for narcotics in the postoperative
setting.
Patients in both the PCA group and the TLC group
experienced “rebound pain”. We demonstrated a
change in pain score from 1.7 to 4.8 between 8 and 24
hours after surgery in the “Traditional group” and a
change in pain score from 1.6 to 3.7 in the TLC group.
We associate this increase in pain scores with the acute
heightened pain experience that occurs after resolution
of the effects of an interscalene brachial plexus
blockade. Alternative strategies to reduce the rebound
pain experience may include intraoperative infiltration
of the soft-tissues with analgesic or anesthestic
medications (20-22). In a meta-analysis that examined
the effects of interscalene brachial plexus blockade on
analgesic outcomes after shoulder surgery, Abdallah
et al reviewed a total of 23 randomized controlled
trials and demonstrated that ISBPB can provide
effective analgesia up 8 hours after shoulder surgery,
with no demonstrable benefits thereafter (23). While
the TLC group experienced a less substantial spike in
pain scores between 8 and 24 hours compared to the
Traditional group, it is unclear whether this difference
is a result of the multimodal analgesic medications
administered or from the increased narcotic utilization
in this group. We hypothesize that the less substantial
spike in pain score in the TLC group may account
for the significantly shorter hospital length of stay
demonstrated in this study. It is important to note that,
though statistically significant, it is unknown whether
a 0.2 day mean difference in length of stay represents a
clinically significant difference.
In both the Traditional and the TLC groups, patients
with higher preoperative VAS pain scores were more
likely to have high 24 hour VAS pain scores. This
association has been previously demonstrated in
studies of open and arthroscopic rotator cuff repair (13,
24). With use of either a Traditional or a TLC protocol,
patients with high preoperative pain scores should be
counseled regarding the challenges they may face in
achieving pain relief in the first 24 hours after surgery.
In this study, preoperative short-acting narcotic usage
was not associated higher pain scores postoperatively.
Other studies have associated preoperative narcotic
utilization with postoperative pain experience after
shoulder surgery. Cuff et al reviewed 181 cases
of arthroscopic rotator cuff repair and noted that
preoperative narcotic use was strongly predictive of
higher pain scores on postoperative days 1 and 7 (25).
We excluded patients taking long-acting narcotics
preoperatively which may account for the lack of this
association in our study.
This study has several limitations. The retrospective
study design is a primary limitation that did not allow
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for assessment of certain variables, such as pain scores
beyond 24 hours after surgery and satisfaction that
could be available in a prospective evaluation. Since
this study investigates a change in protocol over a
specified period of time and since we excluded patients
with certain characteristics (long-term narcotic use,
psychiatric comorbidities, etc) that could create outliers
in each group, we attempted to minimize the impact of
this limitation on the results. Additionally, this study
evaluated a specific TLC protocol; and so, it is not
possible to generalize the results to other multimodal
pain management strategies. We utilized single-injection
interscalene brachial plexus blockade in this study as it
is the standard of care at our hospital. It is likely that
interscalene brachial plexus blockade with placement
of a catheter for continuous infusion of analgesic
medication would have resulted in longer-lasting pain
relief and perhaps a less substantial “rebound pain”
experience. Finally, while reported narcotic usage in
terms of MEUs is common in the literature, there is
growing concern that a single, effective method does not
exist that allows opioids to be accurately and consistently
converted to another opioid (10, 26-29). Similarly, we
compared patients who utilized intravenous narcotics
via a patient controlled pain pump to patients who used
oral narcotics. As intravenous medications are fastacting and short lived; whereas oral opioids are slowly in
onset but result in more sustained effect, the differences
could be explained by the different method of narcotic
administration.
When compared to patients in the “Traditional group”,
those treated with the TLC protocol had greater narcotic
utilization postoperatively but better VAS pain scores
at 24 hours after surgery. Both groups experienced a
substantial increase in pain experience after the 8-hour
time point, indicating the experience of rebound pain
after interscalene brachial plexus blockade. This data
indicates that the non-narcotic medications included in
the TLC protocol were not sufficient to eliminate, or even
reduce, narcotic utilization. While the TLC protocol led
to an improved pain experience, further modification
of the currently protocol may be necessary to reduce
overall narcotic utilization.
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